Home › Funds › MASTERINVEST Kapitalanlage GmbH › ABT

MASTERINVEST Kapitalanlage GmbH position in ABT

ABBOTT LABORATORIES · Health Care

MASTERINVEST Kapitalanlage GmbH reported holding 76,372 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$7.5M, representing 0.64% of its reported portfolio and ranking #29 among its reported holdings. MASTERINVEST Kapitalanlage GmbH has disclosed ABT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)76.37K sh
Reported value held$7.55M
Portfolio Weight0.64%
First reportedQ2 2025
Last changeAdd
Updated2026-11-03

Last updated: 2026-11-03 · Source: SEC EDGAR Form 13F-HR

How MASTERINVEST Kapitalanlage GmbH's ABT position evolved

MASTERINVEST Kapitalanlage GmbH first disclosed a stake in ABT in Q2 2025 at 62,816 shares (US$8.5M). The position peaked in Q3 2025 at 65,108 shares, worth US$8.7M. Across 6 filings, MASTERINVEST Kapitalanlage GmbH increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 76,372 shares valued at US$7.5M — an increase of 4,395 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2025 62.82K $8.54M New
Q3 2025 65.11K $8.72M Add
Q4 2025 65.14K $8.19M Hold
Q1 2026 66.96K $6.87M Add
Q2 2026 71.98K $6.53M Add
Q3 2026 76.37K $7.55M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has MASTERINVEST Kapitalanlage GmbH held ABT?

MASTERINVEST Kapitalanlage GmbH has disclosed ABT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is MASTERINVEST Kapitalanlage GmbH's current position in ABT?

As of Q3 2026, MASTERINVEST Kapitalanlage GmbH holds 76.37K shares of ABT (ABBOTT LABORATORIES), valued at $7.55M, representing 0.64% of its reported portfolio and ranking #29.

Has MASTERINVEST Kapitalanlage GmbH been buying or selling ABT?

In the latest 13F filing (Q3 2026), MASTERINVEST Kapitalanlage GmbH increased its position in ABT. The position peaked in Q3 2025 at 65.11K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.